Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111552200 on December 27, 2001

J. Biol. Chem., Vol. 277, Issue 12, 10162-10172, March 22, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/12/10162    most recent
M111552200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arystarkhova, E.
Right arrow Articles by Sweadner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arystarkhova, E.
Right arrow Articles by Sweadner, K. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Regulation of Renal Na,K-ATPase by Splice Variants of the gamma  Subunit*

Elena Arystarkhova, Claudia Donnet, Natalya K. Asinovski, and Kathleen J. SweadnerDagger

From the Laboratory of Membrane Biology, Neuroscience Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129

Received for publication, December 4, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sodium and potassium-exchanging adenosine triphosphatase (Na,K-ATPase) in the kidney is associated with the gamma  subunit (gamma , FXYD2), a single-span membrane protein that modulates ATPase properties. Rat and human gamma  occur in two splice variants, gamma a and gamma b, with different N termini. Here we investigated their structural heterogeneity and functional effects on Na,K-ATPase properties. Both forms were post-translationally modified during in vitro translation with microsomes, indicating that there are four possible forms of gamma . Site-directed mutagenesis revealed Thr2 and Ser5 as potential sites for post-translational modification. Similar modification can occur in cells, with consequences for Na,K-ATPase properties. We showed previously that stable transfection of gamma a into NRK-52E cells resulted in reduction of apparent affinities for Na+ and K+. Individual clones differed in gamma  post-translational modification, however, and the effect on Na+ affinity was absent in clones with full modification. Here, transfection of gamma b also resulted in clones with or without post-translational modification. Both groups showed a reduction in Na+ affinity, but modification was required for the effect on K+ affinity. There were minor increases in ATP affinity. The physiological importance of the reduction in Na+ affinity was shown by the slower growth of gamma a, gamma b, and gamma b' transfectants in culture. The differential influence of the four structural variants of gamma  on affinities of the Na,K-ATPase for Na+ and K+, together with our previous finding of different distributions of gamma a and gamma b along the rat nephron, suggests a highly specific mode of regulation of sodium pump properties in kidney.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Na,K-ATPase,1 or sodium pump, is the principal enzyme in animal cells that maintains ionic gradients of Na+ and K+ at the expense of ATP hydrolysis. In kidney, the Na+ gradient provides the driving force not only for the reabsorption of sodium, but also for secondary transepithelial transport of various essential solutes and water. Controlling sodium pump activity is thus an essential element of renal regulation.

The Na,K-ATPase has two obligatory subunits, the catalytic alpha  subunit and a glycoprotein, beta , which are encoded by multigene families (1). Expression of alpha  and beta  isoforms is developmentally regulated, and appears to be species- and tissue-specific (2, 3). In several experimental expression systems, the exchange of either alpha  or beta  subunit isoforms affected enzymatic properties of the complex, most notably affinities for K+ and Na+ (3). Functional differences in intrinsic properties of Na,K-ATPase have been reported in the kidney; the affinity for Na+ varies significantly along the rat and rabbit nephron (4-7). This led to an effort in many laboratories to determine whether alpha  and beta  isoforms could account for the differences, but no segment-specific localization of isoforms other than alpha 1 and beta 1 was found for either mRNA or protein (8-12).

Two regulatory proteins that modulate intrinsic properties of the Na,K-ATPase have now been identified in kidney: the Na,K-ATPase gamma  subunit (13, 14), and CHIF ("channel-inducing factor") (15, 16). Based on sequence homology, both proteins belong to the FXYD gene family, which unites small (5-15 kDa) single-span membrane proteins including phospholemman (17), MAT-8 ("mammary tumor antigen-8") (18), RIC ("related to ion channel") (19), as well as two new gene products, called FXYD6 and FXYD7 (20). Although Na,K-ATPase is widely distributed in kidney, expression of gamma  and CHIF is segment-specific. gamma  co-localizes with Na,K-ATPase in proximal tubules, distal convoluted tubules, and medullary thick ascending limb (21-23), whereas CHIF co-localizes with the pump in collecting duct (16).

The functional significance of gamma  (FXYD2) for the Na,K-ATPase complex was a mystery for a long time. The key properties of the Na,K-ATPase (ouabain binding, enzymatic activity, and cation transport) can be obtained without it (24-26). It is also not required for alpha beta assembly and transport of functional units to the plasma membrane (27). However, incorporation of a photoaffinity-labeled derivative of ouabain into gamma  as well as alpha  suggested that it may comprise part of the ouabain-binding site (13).

The first clear effect of gamma  on Na,K-ATPase transport properties was detected by electrophysiological measurements in Xenopus oocytes. It influenced the apparent affinity of the Na,K-ATPase pump current for extracellular K+ (28). An antibody against gamma  inhibited Na,K-ATPase in vitro and decreased affinity for ATP (29). The functional role of gamma  was further assessed with gamma -transfected mammalian cells. In HEK cells, gamma  increased affinity for ATP (30). NRK-52E cells express the same alpha 1beta 1 combination as kidney but no gamma , and apparent affinities for Na+ and K+ were higher than for alpha 1beta 1gamma from renal medulla (31). Stable transfection of gamma a (the only known splice variant at the time) resulted in a reduction of affinities for Na+ and K+. This was observed with partially purified enzyme, indicating a stable functional alteration of enzyme properties. Interestingly, the modulation of Na+ affinity was abolished by a post-translational modification of gamma  that occurred in cell culture and that shifted its gel mobility (31). A comparable decrease in apparent Na+ affinity has recently been ascribed to an increase in K+ antagonism of cytoplasmic Na+ activation in gamma -transfected HeLa cells (21). Similarly, gamma  was shown to influence Na,K-ATPase pump current by lowering the apparent affinity for intracellular Na+ (32). The injection of CHIF cRNA into Xenopus oocytes, in contrast, resulted in an increase in apparent affinity for Na+ (32). Taken together with the almost complementary distributions of gamma  and CHIF along the rat nephron (16, 22), the functional data correlate very well with the differences in Na+ affinities in successive segments of the nephron (4, 6, 7, 33).

In rat kidney, gamma  occurs as at least two splice variants, gamma a and gamma b, with different N termini (20, 34, 35). The splice forms colocalized in the inner stripe of the outer medulla in the thick ascending limb of the loop of Henle (21, 23), and co-immunoprecipitation with each other and alpha  showed that they are associated in macromolecular complexes (23). Our observations indicate that their distribution in renal cortex and outer stripe of the outer medulla, however, is strongly biased to different segments. gamma a predominated in proximal tubules, whereas gamma b was detected only in distal and connecting tubules and the thick ascending limb in the outer stripe (23). Very recently, a third splice variant of gamma  has been described in mouse (36), although not in human (37). All of the splice variants in these characterized genes have different promoters, which provides a basis for differential regulation of gene expression.

Here we have investigated the functional properties of gamma  subunit splice variants. Others have reported that gamma a and gamma b have similar effects on intrinsic properties of the pump. Both splice variants decreased apparent affinity for Na+ without significant alteration of K+ affinity in HeLa transfected cells (21) and in Xenopus oocytes (32), and increased Km for ATP in HeLa transfectants (21). We find, however, that post-translational modifications that occur in some but not all NRK-52E clones stably expressing gamma a or gamma b affect the final enzyme properties; consequently, gamma a can have modulating effects on Na,K-ATPase activity different from that of gamma b. Taken together with the differential distribution of gamma a and gamma b in kidney, the regulatory effects of gamma  on intrinsic properties of the Na,K-ATPase appear to be subject to multiple layers of control. Preliminary reports have been presented (38, 39).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Preparation of Na,K-ATPase from Kidney-- Isolation of membranes and purification of Na,K-ATPase from rat kidney outer medulla and whole mouse kidneys was performed by the Jørgensen procedure (40). Briefly, microsomal fractions were collected by differential centrifugation, followed by SDS treatment and equilibrium centrifugation on sucrose density gradients.

Plasmid Construction and Site-directed Mutagenesis-- cDNA for the gamma b splice variant was obtained by reverse transcriptase-PCR from total rat kidney RNA (CLONTECH). The primers were based on nucleotide sequences for rat gamma b in the dbEST data base (GenBankTM) plus EcoRI and BamHI restriction sites for unidirectional cloning: forward degenerate primer, 5'-GCGAATTCCACCATGGAYAGGTGGTACYTG-3', where Y = (C/T); reverse primer, 5'-CGCGGATCCCAGCTCATCTTCATTGAC-3'. Gel-purified DNA was ligated into pIRES vector (CLONTECH) containing an internal ribosome binding site and the neomycin resistance gene. Several clones containing the full-length cDNA of gamma b were verified by nucleotide sequencing (GenBankTM AF233060). Point mutations were introduced into the gamma a cDNA in the pIRES vector by PCR and confirmed by DNA sequencing.

In Vitro Protein Synthesis-- The full-length cDNAs of rat gamma a (wild type and mutated) and gamma b were ligated into pT7 vector (Novagen) and translated in vitro using the TNT-T7 system (Promega) with or without addition of canine pancreatic microsomes according to the manufacturer's procedure. The reaction was for 90 min at 30 °C, followed by centrifugation in an Airfuge (Beckman) (10 min, 4 °C). The samples were washed with 100 mM NaCl and 25 mM HEPES, pH 7.4, and the final pellets were resuspended in 315 mM sucrose, 1 mM EDTA, and 20 mM Tris-Cl, pH 7.5. Portions were dissolved in SDS sample buffer, run on an SDS-Tricine gel (41), and transferred to nitrocellulose. Detection of the newly synthesized proteins was with the RCT-G1 antibodies against the C terminus of gamma  (31). Luciferase-T7 DNA was used as a positive nonradioactive control; samples without DNA added served as negative controls for transcription/translation background. Blots were scanned with a laser densitometer.

Transfectant Enzyme Preparation and Gel Electrophoresis-- NRK-52E is a rat renal cell line ("normal rat kidney") with polarized epithelial morphology. Transfection of NRK-52E cells and selection of gamma b-containing stable clones were performed as before for gamma a (31), and isolated clones were propagated in the presence of G418 antibiotic selection. Purification of the Na,K-ATPase from mock- or gamma -transfected cells was as described (31). Briefly, cells were grown in 75-cm2 flasks until confluent in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, washed with Dulbecco's PBS, and frozen. Crude membranes from the scraped cells were obtained by homogenization and differential centrifugation. Final purification of Na,K-ATPase was with SDS extraction, which leaves the protein in the lipid bilayer but removes many contaminating proteins.

Electrophoresis was in SDS-Tricine gels (41). Proteins were transferred to nitrocellulose, and the blots were incubated with specific antibodies. Detection was with chemiluminescence (Pierce). The RCT-G1 polyclonal antibody raised against the C-terminal peptide of gamma  (31) was employed to detect both splice variants of the protein. The RNGB antibody (rat N terminus of gamma b) (23) was used for gamma b detection. Monoclonal antibody McK1 was used to stain alpha 1 (42).

Enzymatic Assays-- Na,K-ATPase activity was measured as a function of Na+ concentration in media containing 3 mM Tris-ATP, 3 mM MgCl2, 30 mM histidine, pH 7.4, and in the presence of various concentrations of K+ (5-100 mM). Na,K-ATPase activity was also measured as a function of K+ concentration (0-20 mM) with fixed [Na+] at 140 mM. ATP activation curves were obtained with 140 mM Na+, 20 mM K+, and 4 mM Mg2+ in the reaction medium. All the reactions were performed at 37 °C for 30-45 min with and without 3 mM ouabain, and ouabain-sensitive Pi release was measured colorimetrically by using either Fiske-Subbarow or Baginski methods, or by release of 32P from [gamma -32P]ATP. Data were analyzed by nonlinear regression using Sigma Plot Graph System (Jandel Scientific). Na+ and K+ activation curves were fitted according to the Hill model for ligand binding. Km values for ATP stimulation were derived from the Michaelis-Menten equation, also by nonlinear regression. Student's statistical test was used to assess differences.

An exception to the above methods applies to data replotted from Ref. 43. There, activity was assayed continuously in a spectrophotometric coupled assay performed in a thermostatted cuvette. Assays were performed with different starting K+ concentrations and nominally zero Na+, and aliquots of NaCl were added successively, allowing determination of a new slope with each addition.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Gel Mobility and Biosynthesis of the gamma  Structural Variants-- Although it is well accepted that there are two gamma  splice variants in the rat (20, 21, 23, 32, 34, 35), the nature and role of structural modifications of these variants have been controversial. Here we begin by examining the electrophoretic mobilities of gamma  forms found in kidney, and then use in vitro translation of gamma a and gamma b to detect post-translational modification of both splice variants.

Fig. 1A demonstrates gamma  band resolution in gels of typical preparations of Na,K-ATPase from rat and mouse kidney. The blot was stained with the RCT-G1 antibody that recognizes the C terminus of gamma , a site that is highly conserved between species and identical in the splice variants. gamma  was seen as a clear doublet in both species, although the resolution was significantly better for mouse.2 A similar slower migration of gamma a was observed in Na,K-ATPase preparations from sheep kidney (not shown). Based on gel mobility, we estimated the differences in apparent molecular masses for splice variants as 1.5 and 2.5 kDa for rat and mouse, respectively, with gamma a appearing larger. For the rat, the calculated molecular masses based on amino acid sequence are almost identical, however: 7245.7 for gamma a and 7234.8 for gamma b, assuming no modification or oxidation. Determination of the molecular masses by mass spectrometry revealed 7184.0 ± 1 for rat gamma a (with carbamidomethyl cysteine and without initiator methionine) and 7337.9 ± 1 for rat gamma b (with carbamidomethyl cysteine and with acetylated methionine) (35), indicating that the larger species actually migrates faster. The sequence of mouse gamma a is four amino acids longer (Fig. 1B), and the calculated difference between molecular masses of unmodified mouse gamma a and gamma b is about 300 (7515.9 for gamma a versus 7204.7 for gamma b). For both species, the calculated masses are close enough that the proteins could co-migrate on SDS gels, but splice variants of gamma  are generally seen as a doublet (23, 32, 35). Thus, the apparent difference in electrophoretic mobility must be influenced by something else, such as net charge or a labile post-translational modification.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   Species-specific difference in electrophoretic mobility of gamma  on SDS gels. A, purified preparations of Na,K-ATPase from rat kidney outer medulla and whole mouse kidneys were run on a 12.5% Tricine gel and transferred to nitrocellulose, and the blot was stained with the RCT-G1 antibody. Migration of gamma a in mouse was significantly slower than in rat. B, alignment of the N-terminal amino acid sequences of gamma a and gamma b from rat and mouse.

We investigated the electrophoretic mobilities by analyzing proteins translated in vitro from synthetic mRNA. First we examined proteins made in reticulocyte lysates without addition of any microsomes. Newly synthesized proteins were analyzed on SDS-Tricine gels and stained with the RCT-G1 antibody, the blot was scanned with a laser densitometer, and the scans were superimposed. As shown in Fig. 2A, the splice variants of rat gamma  migrated at different rates, gamma a slower than gamma b, as shown with tissue-derived samples (23, 35).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro synthesis of the rat gamma  subunit. cDNAs for rat gamma a and gamma b were transcribed and translated in a reticulocyte system in the absence (A) or presence (B and C) of canine pancreatic microsomes (PM). Newly synthesized proteins were run on Tricine-SDS gels. The blots were stained with the RCT-G1 antibody and scanned with a laser densitometer from top to bottom. Staining of gamma  is expressed in arbitrary units, and its relative position on the gel is marked with arrows.

Addition of endoplasmic reticulum to the reaction mixture permits ribosome attachment and cotranslational membrane protein insertion. When canine pancreatic microsomes were added to the reaction mixture, the electrophoretic mobility of both proteins was decreased, implying that both splice variants can be post-translationally modified (Fig. 2, B and C). The shift observed for gamma a was more pronounced than that for gamma b, indicating either different types of modification, or modification of more sites in gamma a. Either way, the difference in the shift between the splice variants is conjectural evidence that the location of the modification is in the spliced N-terminal segment, and that it occurs in the lumen of rough microsomes. Beguin et al. (32) reported similar shifts in electrophoretic mobility for both splice variants of gamma  synthesized in a reticulocyte system supplemented with microsomes. Thus gamma  may exist (at least in vitro) in four different structural forms: gamma a, gamma a', gamma b, and gamma b', where the mark represents post-translational modification(s).

To identify possible sites of modification by acylation or esterification, we mutated the oxygen-containing residues of the N-terminal segment of gamma . Thr2 and Ser5 residues are conserved in gamma a from all mammalian species characterized so far (20). Site-directed mutagenesis to alanine was followed by in vitro translation and electrophoresis. As shown in Fig. 3, both residues appeared to be important for post-translational modification. Mutations of either Thr2 or Ser5 almost completely blocked the shift in mobility of gamma a seen with pancreatic microsomes. However, when Ser11, a potential site for modification in the sequence shared by gamma a and gamma b, was replaced by Ala, migration of the mutated protein was reduced to an intermediate position (Fig. 3C). In the absence of microsomes, all mutants migrated at the same position as their unmutated form (data not shown). The data are consistent with a possible cooperative modification of gamma a at two sites within the extracellular N-terminal splice domain of gamma a, and one in shared sequence. Alternatively, structural perturbation of the extreme N terminus of gamma a could prevent recognition by the modifying enzyme(s).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of mutations on electrophoretic mobility of gamma a. cDNAs for rat wild type or mutated gamma a were transcribed and translated in vitro, and analyzed as in Fig. 2. Electrophoretic positions are shown for wild type gamma a synthesized in the presence (red) or absence (black) of pancreatic microsomes and mutated gamma a synthesized in the presence of pancreatic microsomes (blue), run on the same gel. Replacement of either Thr2 or Ser5 with Ala (T2A and S5A, respectively) significantly blocked the shift in mobility of gamma a. Replacement of Ser11 (S11A) resulted in an intermediate shift of mobility.

Expression of Two gamma b Forms in NRK-52E Cells-- To test whether gamma b affects function of the pump, stable transfectants of NRK-52E cells were generated as done previously for gamma a (31). Expression of gamma b is shown in Fig. 4. The level of expression in different clones, relative to alpha  subunit, varied between 20 and 80% of the level of gamma b detected in rat kidney membranes (mean, 50-60%). Two groups of clones were identified based on electrophoretic mobility. In some clones (3 of 9 analyzed) gamma b comigrated with gamma b synthesized in vitro (data not shown). In the majority of clones, however, gamma b migrated slower (compare lane 1 with lanes 3 and 4, Fig. 4A). The shift in electrophoretic mobility was similar to that observed in vitro upon the addition of canine pancreatic microsomes (Fig. 2). The difference in migration of gamma b in transfectants was apparent in either crude membrane preparations or partially purified enzyme (data not shown), indicating that difference in mobility was not a purification artifact. Both N and C termini of gamma b were preserved in these preparations because the difference in electrophoretic mobility was seen either with RCT-G1 (Fig. 4A) or RNGB (Fig. 4B) antibodies. This ruled out the possibility of proteolysis, pointing to other post-translational modification as the cause of differences in electrophoretic mobility for gamma b in transfected cells. Because the NRK-52E cell line is morphologically heterogeneous (unpublished observations), cells with different phenotypes might have different cell machinery with respect to gamma b modification similar to the differences already observed in gamma a transfected cells (31).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   Expression of gamma b in NRK-52E cells. A, purified preparations of Na,K-ATPase from rat kidney (lane 2), gamma b (lane 1), and gamma b' (lanes 3 and 4) expressing clones were run on Tricine SDS gels (5.5 inches long). The blots were cut in the middle, and the upper portion was stained with McK1 (alpha 1-specific antibody), whereas the bottom panel was stained with RCT-G1 (antibody to the C terminus of gamma ). B, preparations of Na,K-ATPase from rat kidney (lane 1), gamma b (lane 2) and gamma b' (lane 3) expressing clones were electrophoretically separated as in A, and stained with RNGB (antibody to the N terminus of gamma b). The shift in mobility was detected with both gamma -specific antibodies, suggesting a post-translational modification of gamma b. C, purified preparations of Na,K-ATPase from gamma a (partially modified) (lane 1) and gamma b' (lane 2) clones were run separately or together (lane 3). The blot was stained with RCT-G1 antibody. Unmodified gamma a on the gel could not be resolved from gamma b.

The shift in mobility of gamma b in different clones was reliably seen only when electrophoretic separation was performed on long (5.5-inch) Tricine gels (12.5% acrylamide), suggesting that the size of the modifying group was rather small or that it cancelled some other subtle effect on anomalous mobility. Conversely, when gamma a was post-translationally modified in NRK-transfected cells, the shift in electrophoretic mobility was visible even on minigels (2.5-inch) (31). Thus different types of modification (or numbers of residues modified) were apparently exploited in gamma a and gamma b transfectants. The data are in line with our in vitro translation studies, thus providing further support for the structural complexity of gamma .

Fig. 4C shows an experiment in which membrane preparations from clones containing modified gamma b and heterogeneously modified gamma a (31) were mixed together and separated on a long (5.5-inch) Tricine gel. Surprisingly, a doublet (not a triplet as expected) was observed with the RCT-G1 antibodies, which shared a thick band at the lower position. This implies that the electrophoretic mobility of modified gamma b can coincide with that of unmodified gamma a on Tricine gels, complicating the analysis of gamma  structural forms.

Functional Effects of the gamma  Splice Variants on Na,K-ATPase Activity-- Na+, K+, and ATP ligand dependences of the Na,K-ATPase from gamma b-transfected cells were determined and compared with those from gamma a- and mock-transfected cells. As in our previous study (31), we worked with individually isolated stable clones, and all of the assays were performed on partially purified preparations of Na,K-ATPase. Three clones expressing gamma b and six clones expressing gamma b' were analyzed. The data shown summarize multiple experiments.

Variations in the total specific activity between clones precluded any evaluation of an effect of gamma  expression on Vmax. Specific activity was in the range of 50-150 µmol of Pi/mg protein/h. As shown in Fig. 5A, the apparent affinity for Na+ was significantly decreased when either gamma b or gamma b' was expressed. Based on nonlinear regression analysis of data fit to the Hill equation, K0.5 for Na+ was shifted from 5.4 mM in wild-type NRK-52E cells to 7.3-7.4 mM for gamma b when measured in the presence of 20 mM K+ (Table I). Na,K-ATPase from rat kidney possessed an even lower apparent affinity for sodium (9.5 ± 0.4 mM). Apparently, post-translational modification of gamma b did not influence its effect on Na+ affinity because similar changes were observed in both types of gamma b-containing clones (Fig. 5A). The data substantiate the conclusion that the major consequence of gamma  association with the Na,K-ATPase is a decrease of apparent affinity for Na+ (21, 31, 32).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of gamma  on Na+, K+, and ATP affinity by Na,K-ATPase in transfected NRK-52E cells. A, activity of partially purified Na,K-ATPase from mock-transfected (red) or gamma b-transfected (blue and green) cells was tested as a function of Na+ concentration at a fixed K+ concentration of 20 mM. Data from Na,K-ATPase purified from rat renal medulla (black) are shown for comparison. Each set of data points is the mean ± S.D. from at least four independent experiments (with duplicate determinations) expressed as percentage of maximal Na,K-ATPase activity. The data were fitted to Equation 1. Na+ affinity of Na,K-ATPase was altered by gamma b regardless of post-translational modification: gamma b (blue) and gamma b' (green) caused a similar decrease in apparent affinity for Na+. B, preparations of Na,K-ATPase from rat kidney (black), mock-transfected (red), or gamma b and gamma b'-transfected cells (blue and green, respectively) were assayed for ATPase activity as a function of K+ concentration. Each set of data points shown is the mean ± S.D. from at least five independent experiments (with duplicate determinations) expressed as percentage of the ATPase activity at 20 mM K+. The data were fitted to Equation 1. Post-translational modification of gamma b resulted in modulation of the apparent affinity for K+. C, purified preparations of Na,K-ATPase from rat kidney (black), mock-transfected (red), gamma a-transfected (purple and cyan), and gamma b-transfected (blue and green) NRK-52E cells were assayed with concentrations of ATP from 50 µM to 1.5 mM. Data were analyzed by the Michaelis-Menten equation. Each set of data is the mean ± S.D. from at least three independent experiments (with duplicate determinations). Affinity for ATP was slightly different in transfected cells expressing different structural forms of gamma .

                              
View this table:
[in this window]
[in a new window]
 
Table I
Differential effects of structural forms of gamma  on affinity for Na+ and K+
Affinities were determined with partially purified Na,K-ATPase preparations from transfected NRK-52E cells or from rat kidney medulla. Na+ and K+ activation curves were fitted according to a cooperative model for ligand binding. The apparent affinity K0.5 = K1/n, where n is the Hill coefficient, nh. Clones expressing gamma a as a doublet were incompletely post-translationally modified. The data shown for gamma a doublet clones combine data published previously (31) with additional experiments. The data marked with double asterisks are taken from (31). Multiple tests of significance were performed.

As we reported previously (31), the apparent affinity for K+ was also higher in Na,K-ATPase from gamma -deficient NRK-52E cells than from rat kidney membranes, and so we evaluated the contribution of gamma b. The two groups of clones expressing gamma b or gamma b' were examined, and data from multiple experiments were statistically analyzed. Fig. 5B shows that expression of unmodified gamma b did not change the apparent affinity for K+ compared with mock-transfected NRK cells. However, with gamma b', K0.5 for K+ was significantly increased from 0.45 ± 0.05 mM (control cells) to 0.75 ± 0.08 mM (gamma b' transfectants) (Table I). It should be noted here that the assay was performed in the presence of 100 mM Na+, i.e. in conditions in which the kinetics of activation by K+ depend on both the intrinsic affinity for K+ and on competition between extracellular Na+ and K+ ions. Beguin et al. (32) have observed that this is affected by both gamma  and CHIF in a voltage-dependent manner. Their data at 0 mV (corresponding to our experiments in open membranes) show a similar tendency to lower K+ affinity with gamma , and an opposite tendency to higher affinity when oocytes are hyperpolarized. In our previous work (31), introduction of gamma a caused a similar reduction in the apparent affinity for K+ (from 0.44 ± 0.03 mM to 0.70 ± 0.04 mM, in mock- and gamma -transfected enzyme, respectively). However, the post-translational modification of gamma a did not alter the effect on K+ affinity, whereas it eliminated the reduction in apparent affinity for Na+. Thus, the four structural forms of gamma  differentially influenced the kinetic parameters of the Na,K-ATPase for its major physiological ligands.

Similar to the two other kinetic parameters (apparent affinity for Na+ and K+), the Km for ATP (at the low affinity site) was lower in wild type NRK-52E cells compared with rat kidney membranes (Table II). Transfection with gamma  did not make the ATP affinity more like that of the kidney enzyme, however. Instead it further increased the affinity for at least two of the molecular forms (Fig. 5C), gamma b and fully modified gamma a' (Table II). However, we did not see any effects that reached statistical significance on Km for ATP for either gamma a (partially modified) or gamma b', nor did any of the changes reach statistical significance compared with mock-transfected cells (Table II). Although the difference in Km ATP displayed by the two gamma b forms was statistically significant from each other (p = 0.021 by Student's test), the effect was nevertheless very modest. As mentioned above, the level of expression in the transfected cells was never as high as in rat kidney membranes. Thus, the possible interpretation is that association of unmodified gamma b or fully modified gamma a with Na,K-ATPase may lead to a decrease in Km values for ATP. This is roughly consistent with prior reports (21, 30) and does not explain the higher Km observed in alpha beta gamma -containing rat kidney membranes.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effect of expression of gamma  on affinity for ATP in different cell lines
Km values for ATP for Na,K-ATPase isolated from NRK-52E cells (transfected or mock-transfected) were calculated from the Michaelis-Menten equation. Multiple tests of significance were applied to our own data.

Mechanistic Analysis of the K+ Effect on Na+ Affinity-- Two alternative equations describing Hill (Equation 1) and noninteractive (Equation 2) models were used to fit the Na+ affinity data (Fig. 6A).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 6.   Kinetic analysis of Na+/K+ competition. A, in a typical experiment to determine apparent affinity for Na+, Na,K-ATPase activity was measured in the presence of different concentrations of Na+ and 100 mM K+ in preparations from NRK-52E cells (open circles) and a gamma a transfectant (closed circles). Lines represent the best fit to Equation 1. The inset shows the best fit to Equation 1 (continuous line) as well as for Equation 2 (dashes). Curve-fitting was carried out using SigmaPlot software (Jandel Scientific). The concentration variable was assumed to be homoscedastic. The data are displayed as means ± S.E. B, multiple individual experiments similar to the one depicted in A were performed in the presence of fixed concentrations of 5, 20, 50, or 100 mM K+. K'Na were obtained by fitting with Equation 1 and were plotted against K+ concentration. The curves were drawn by splines. C, to assess whether addition of choline to keep ionic strength constant affects the linearity of the plot of K'Na versus [K+], rat renal medulla Na,K-ATPase was assayed with (closed circles, A) and without choline (open circles, B). The other data (triangles, C) are also from an experiment with rat renal medulla Na,K-ATPase, but data are replotted from Ref. 43, where the data were initially interpreted as fitting a straight line. Dashed lines (A, B, and C) are the best fit to Equation 3, and the solid lines are drawn as splines. D, K'Na versus [K+] for the control NRK-52E cell preparation of panel 2 is shown for K'Na determined from either Equation 1 (open circles) or Equation 2 (closed circles). K'Na for Equation 2 is one eighth of maximal activity, whereas for Equation 1 it is one half of maximal, but both plots are nonlinear.


&ngr;=<FR><NU>V<SUB>m</SUB></NU><DE><FENCE>1+<FR><NU>K′<SUB><UP>Na</UP></SUB><SUP>h</SUP></NU><DE>[<UP>Na</UP><SUP>+</SUP>]<SUP>h</SUP></DE></FR></FENCE></DE></FR> (Eq. 1)

&ngr;=<FR><NU>V<SUB>m</SUB></NU><DE><FENCE>1+<FR><NU>K′<SUB><UP>Na</UP></SUB></NU><DE>[<UP>Na</UP><SUP>+</SUP>]</DE></FR></FENCE><SUP>3</SUP></DE></FR> (Eq. 2)
Vm is the activity obtained at optimum Na+ concentration, h is the Hill coefficient, and K'Na is a measure of the apparent affinity for Na+. Equation 1 implies allosteric interaction between the sites for Na+. Equation 2 would apply if there is no interaction between three equivalent Na+ binding sites, but all three sites must be loaded (44). It should be noticed that K'Na, a measure of the apparent affinity for Na+, has different meanings in each equation, being the Na+ concentration that gives the half-maximal velocity in Equation 1, but the concentration giving one eighth of the maximal velocity in Equation 2. It can be seen in Fig. 6A that Equation 1 fit our data with less bias, suggesting that the noninteracting site model may not apply.

The decrease in apparent affinity for Na+ observed in gamma -transfected HeLa cells has been analyzed kinetically and concluded to be caused by an increase in K+ antagonism of Na+ binding at cytoplasmic sites (21). Here, an extensive kinetic analysis was performed to evaluate the influence of K+ concentration on apparent affinity for Na+ in gamma a-transfected NRK-52E cells. Affinities obtained through fitting the data with Equation 1 were plotted versus K+ concentration (Fig. 6B) for enzyme either lacking or containing gamma a. It can be seen that the apparent affinity for Na+ decreased as K+ concentration rose, loosely in agreement with prior work (21) and that, at all K+ concentrations, gamma  reduced the apparent Na+ affinity. However, in our hands the shape for the plot of K'Na versus K+ concentration was not linear, suggesting that mechanisms other than K/Na antagonism alone are involved. As shown in Table III, there were technical differences such as in the concentration of free Mg2+, which will be discussed below.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Experimental differences in K+/Na+ competition determinations
Concentrations are in mM. Free concentrations of Mg2+ and ATP were calculated with the program WEBMAXC, version 2.10, taking into account the ionic strength and pH as well as the listed Mg2+-binding ligands.

A nonlinear plot of K'Na versus [K+] is unexpected, because in earlier studies with various preparations (21, 43-46), K+ competition for Na+ activation could be described by the simple equation shown below.
K′<SUB><UP>Na</UP></SUB>=K<SUB><UP>Na</UP></SUB>(1+[K<SUP>+</SUP>]/K<SUB><UP>K</UP></SUB>) (Eq. 3)
K'Na is the apparent affinity derived from Equation 1 or 2, KNa is the Na+ affinity extrapolated to zero K+, and KK is the affinity for K+ as a competitor of Na+ binding. Fig. 6C shows, however, that nonlinear plots can also be obtained with rat kidney Na,K-ATPase preparations. We replotted old data from Ref. 43, which were initially interpreted as linear, as well as new data obtained with and without choline added to keep ionic strength constant. Addition of choline shifted the curve to the right at the lower ionic strengths, but did not eliminate the nonlinearity. The solid lines are splines connecting the points, whereas the dashed lines represent the fit to Equation 3, which was poor. Although not as sigmoidal as the data obtained with the NRK-52E transfectants, nonetheless a simple model based on competition between Na+ and K+ for equivalent, noninteracting sites was not supported in these experimental conditions.

Finally, to rule out any possibility that the method used to calculate K'Na was responsible for the nonlinearity of the final plot, we recalculated the Na+ affinity data for mock-transfected NRK-52E cells using Equation 2 instead of Equation 1. Fig. 6D illustrates the difference in absolute values for K'Na (1/2 versus 1/8 of Vmax) obtained with the two equations, and that the data plotted either way were nonlinear.

Physiological Consequences of gamma  Expression-- We have reported previously that gamma a transfected cells displaying gamma  as a doublet had slower growth rate than cells transfected with empty vector or cells expressing a single band (47). Here we extended our studies with the analysis of the gamma b transfectants. As shown in Fig. 7A, cell growth was reduced compared with the mock-transfected cells, and the delay was somewhat greater than that caused in the partially modified gamma a clones. Practically no disparity in cell growth was observed between the clones containing gamma b or gamma b' (Fig. 7B), suggesting that the alteration in K+ affinity did not affect cell proliferation. The 1.5-2-fold greater reduction in the gamma b clones than in the gamma a clone in the second experiment may reflect a higher level of gamma  expression in the gamma b clones. Because all three groups of clones (gamma a doublet, gamma b, and gamma b') possessed lower affinity for Na+ than control cells, whereas clones with fully modified gamma a have normal growth rate (47), the interpretation is that gamma  has a deleterious effect on cell proliferation because of a reduction of Na,K-ATPase affinity for Na+.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   Expression of gamma  affected NRK-52E growth rate. A and B show two different sets of experiments in which the number of cells per well was determined at 24-h intervals. Mock-transfected cells (open circles), or NRK-5E cells transfected with gamma a (incompletely modified, solid circles), gamma b (solid squares), or gamma b' (solid triangles) were plated at 3 × 104 cells/well in six-well plates, harvested by trypsinization, and counted with a hemacytometer. The data summarize the results of three independent experiments where each data point represents triplicates. The data were fitted to a logarithmic growth curve. Reduction in Na+ but not in K+ affinity correlated with the slower rate of cell proliferation.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Regulation of Na,K-ATPase activity in kidney is under several layers of control (48). Although long term alterations involve changes in the number of pump units at the level of gene expression, short term regulators cause rapid modulation of enzyme activity either through recruitment of a latent pool of Na,K-ATPase or through fine-tuning of already existing complexes. The discovery that small single-span membrane proteins (the gamma  subunit and CHIF) regulate the intrinsic properties of the pump through association with alpha beta provides an additional framework for understanding renal control of Na+ and K+ balance. A fundamental issue is why different splice variants of gamma  are expressed in kidney and whether they serve distinct functions. The major outcome is the observation that the splice variants may in fact differentially influence the affinities for the major ligands, Na+ and K+.

Structural Forms of gamma -- The appearance of gamma  on SDS gels was a mystery for a long time. The doublet was first interpreted as post-translational modification of the protein based on in vitro biosynthesis studies (14). In papers from 1999 and earlier, interpretations of doublets as modified forms of a single gamma  subunit, as well as interpretations of the significance of their susceptibility to tryptic digestion, were confounded by not knowing about gamma b (29-31). More recently, genetic analysis (20, 36, 37), mass spectroscopy (35), and immunostaining with specific antibodies (23, 35) showed splice variants to form the gamma  doublet. We have confirmed these conclusions with in vitro translation; despite the very close molecular masses of gamma a and gamma b, the proteins migrated differently on SDS gels. The electrophoretic separation was even more pronounced when canine microsomes were added. Evidence was obtained that both splice variants can be post-translationally modified, yielding four structural forms of gamma . Our findings are in line with the recent report that demonstrated that both splice variants of gamma  were susceptible to post-translational modification in vitro, as was CHIF (32). Interestingly, our data showed that, despite the extensive identity between gamma a and gamma b, their susceptibility to modification in vitro appeared to be different. The electrophoretic mobility of gamma b was changed to a lesser extent than that of gamma a, implying involvement of the variable N-terminal segment. This was supported by site-directed mutagenesis in the N-terminal segment of gamma a. When either Thr2 or Ser5 was replaced by Ala, the change in mobility upon addition of pancreatic microsomes was almost completely blocked. On the other hand, some shift in mobility was retained when Ser11 was replaced. The results suggest that the observed changes in migration were not caused simply by substitution of hydrophobic for oxygen-containing amino acids, and that modification of more than one site may be involved in gamma a, perhaps including Ser11 in the shared sequence. Others have reported that mutations outside of the N terminus (the common FXYD motif and C-terminal domain) had no effect on formation of doublets (32).

The factors that determine the anomalous mobility of gamma  splice variants are not clear, but something similar occurs with the catalytic subunit of the Na,K-ATPase, where alpha 3, the smallest among the four known isoforms, migrates slowest. The N terminus of gamma b has more bulky hydrophobic residues (tryptophan, tyrosine) and less net negative charge than that of gamma a.

Mass spectroscopy of gamma  from rat kidney did not reveal any sign of modified structure other than removal of the N-terminal methionine from gamma a and acetylation of the N-terminal methionine in gamma b (35). Although the size of the acetyl group is rather small to be detected on SDS gels (42 Da), it could have changed the binding of SDS through an effect on charge. Because we found functional differences between gamma b and gamma b', the challenge would be to test whether deacetylation of gamma b could in fact lead to modulation of apparent affinity for K+. Interestingly, there is a precedent from the literature that acetylation of the N-terminal methionine in phospholamban, a single-span regulatory protein from a different gene family, significantly changed its inhibition of the sarcoplasmic, endoplasmic reticulum Ca2+-ATPase (49).

The findings suggesting no other post-translational modification of gamma  in kidney (35) must be considered carefully. First, the post-translational modification(s) could be chemically unstable in the conditions used for peptide purification. Both gamma  bands had blocked N termini, precluding direct sequencing (29), but this would not be expected for gamma a if it has no initiation methionine and no other added mass. Second, the Na,K-ATPase used for mass spectroscopy was apparently purified from rat kidney outer medulla (based on its high specific activity). We, however, have identified proximal tubules as a potential source for modified gamma a, which migrated slower on SDS gels compared with samples from outer medulla (23). Finally, post-translational modification of the protein could be dependent on the physiological status of the animal, and turned on and off in response to need. The mass spectroscopy studies were performed with hypertensive rats (35). Regulation of Na,K-ATPase is known to be implicated in hypertension (50).

Three lines of evidence demonstrate that gamma  undergoes post-translational modification when expressed in NRK-52E cells. First, shifts in electrophoretic mobility in transfected cells were always toward higher molecular weight species. Second, with specific antibodies, we showed that both N and C termini of gamma b were preserved. (Unfortunately, the available antibodies against the N terminus of gamma a do not recognize the SDS-denatured protein with enough sensitivity to do this experiment.) Third, the changes in the migration rate of gamma a and gamma b from transfectants were similar to that observed during in vitro translation with and without pancreatic microsomes.

Additional bands seen on Western blots of transfected HeLa and HEK cells (21, 30, 35) have led to some confusion, however. In both cell types, gamma a in transfectants appeared to migrate faster than the upper band of the kidney-derived doublet (35). Because the blot was stained for the C terminus, this could be indicative of either proteolysis at the N terminus of gamma a in transfectants or a post-translational modification of gamma a in renal membranes. The lower band seen in HEK-gamma a could conceivably represent a product of proteolysis or, alternatively, an adduct with a qualitatively different effect on mobility. The position of the upper band in HeLa-gamma b (21) was much higher than would be expected for modified gamma b based on in vitro translation studies (this work or Ref. 32). Further identification of cell-specific modifications of gamma  and elucidation of its possible role in the Na,K-ATPase are required.

Functional Effects of gamma : Apparent Affinities for Ions and ATP-- General agreement has finally been reached that a major effect of gamma  is related to Na+ affinity (21, 28, 30-32). This is supported by our recent finding that renal Na,K-ATPase from gamma  knock-out mice displayed higher affinity for Na+ than that from wild type animals.3 Beguin et al. (32) also showed in Xenopus oocytes that gamma  decreased the apparent affinity for extracellular K+, and only in the presence of extracellular Na+, although it was not possible to evaluate the functional impact of post-translational modification because oocytes apparently lack the necessary machinery. The consequences of post-translational modification and effects of gamma  on ATP affinity are not well understood, and there are differences in technical details, and in interpretations of results, that should be reconciled.

The observation that Na+ and K+ affinities could be modified independently of each other through modification of gamma a and gamma b (Table IV) implies that the structural differences are functionally important. The only sequence difference is in the short N-terminal stretch exposed outside the cell (28, 30). It is attractive to hypothesize that this segment, through its interaction with extracellular segments of alpha  and/or beta , influences the ion-binding sites within the ATPase complex. The independent changes of Na+ and K+ affinity (Table IV) do not follow either from the proposal that gamma  stabilizes the E1 conformation, or from the proposal that K+ affinity as a competitor of Na+ activation can somehow be varied without effect on intrinsic Na+ affinity or distribution between E1 and E2 forms (51). Furthermore, effects on Km for ATP that appear to be consistent with gamma  stabilization of E1 are seen in all three transfected cell lines (Table II), but do not explain the different ATP affinities among the cell lines and gamma -containing renal Na,K-ATPase. Experiments with gamma  knock-out animals also suggest that elimination of gamma  does not result in a statistically significant change in ATP affinity in mouse kidney.3

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Functional consequences of the expression of gamma  in NRK-52E cells

Divergent results and interpretations may be because of differences in expression systems used. We analyzed multiple stable transfectants of rat gamma  in normal rat kidney cells that express rat alpha 1beta 1 and no other known Na,K-ATPase subunit isoform. Pu et al. (21) have ruled out that the use of human alpha 1 instead of rat alpha 1 influenced the functional effect in transfections of HeLa cells with rat gamma . However, there is no evidence excluding functional association of gamma  with the glycoprotein beta  subunit. The human beta  subunit(s) expressed in HEK (human embryonic kidney) cells has not been determined to our knowledge, but human embryonic kidney expresses beta 2 in vivo (52). We have found both beta 1 and beta 3 to be expressed in HeLa cells (data not shown). Although there is a high degree of homology between human and rat beta 1, there are some structural variations (17/304 substitutions) that might affect subunit interactions, and beta 2 and beta 3 are significantly divergent (32-34% identity to beta 1).

K+/Na+ Antagonism-- Na+ is normally rate-limiting for Na,K-ATPase enzyme activity, and so changes in effective Na+ affinity should have direct physiological consequences by regulating net activity in tissues. The practical issue is that the concentration of intracellular K+ exceeds that of Na+ by a factor of 30, and the ions are thought to be transported in a ping-pong manner, utilizing the same sites. Of the three cytoplasmic ion binding sites, the first two to be occupied do not have a marked preference for Na+, whereas the third site apparently binds Na+ exclusively (53). The lack of specificity of two of the sites results in K+/Na+ competition.

Recently, Pu et al. (21) found linear relationships with different slopes for apparent Na+ affinity plotted as a function of concentration of competing K+, and concluded that the mechanism of gamma  entailed an increase in K+/Na+ antagonism at the intracellular Na+ binding sites, without effect on intrinsic Na+ affinity (21, 51). They used a noninteractive site model to calculate K'Na (Equation 2 shown above), put forward originally by Garay and Garrahan in 1973 (44), and showed data compatible with simple competition of K+ for the Na+ sites (21). Sachs (45) reported similar linearity in erythrocyte ghosts, like the original studies on erythrocyte ion fluxes (44). The concept that gamma  changes K+/Na+ competition has appeal because the Blostein group has previously demonstrated tissue-specific (not isoform-specific) differences in K+/Na+ antagonism (46, 54), which could conceivably be because of expression of gamma  or other FXYD family members modulating the intrinsic properties of the pump. Our data, in contrast, showed a nonlinear increase in apparent affinity for Na+ with increasing concentrations of K+ that tended to decline to a plateau. The presence of gamma  shifted the curve to higher values but the shift was not as strongly dependent on K+ as described by Pu et al. (21). In addition, the slopes did not have the same intercepts, suggesting intrinsically different Na+ affinities in the presence and absence of gamma .

Although the final results and interpretation seem to be different from ours, there are several practical considerations that may reconcile the findings. The kinetic model used may have contributed to the difference, although it cannot explain it alone. The model they used assumes that K+ competes with Na+ binding to any one of three equivalent sites on the cytoplasmic surface and includes no provision for cooperativity or ordered binding and release. More is known currently about the kinetics and properties of ion binding than in 1973, and it is well documented that binding of the first and second Na+ differs substantially from the binding of the third Na+ in both character (electroneutral versus electrogenic) and affinity (53, 55). Strictly ordered release of the three Na+ ions has been also shown for Na,K-ATPase (56). To analyze our current data with gamma  transfectants, we derived K'Na from a cooperative model (Equation 1) rather than a noncooperative one (Equation 2). It can be seen that equation 1 showed less bias and better described our experimental results, something that has also been found by others (57). Measurement of pump currents as a function of Na+ concentration has also been shown to be well described by a Hill equation (32, 58, 59). For comparison, we re-analyzed our data with the noninteractive model (Equation 2). The data were still nonlinear, but the nonlinearity was less obvious. Therefore, it is plausible that K+ competition for Na+ binding may be more complex than the simplest model suggests, depending on the specific conditions and occupancy of the sites.

A technical difference between the Pu et al. (21) data and ours is that we did not keep the ionic strength constant, whereas they kept constant ionic strength by addition of choline. Choline is not inert in its effect on Na,K-ATPase, tending to favor the E1 conformation (60, 61). In control experiments performed with renal medulla Na,K-ATPase preparations, we found a rightward shift from choline addition and somewhat less nonlinearity, although the final relation was still nonlinear.

The other relevant feature of competition at the cytoplasmic Na+ sites is that it is by no means limited to K+. Mg2+ is perhaps the best known physiological competitor (62-65), but even Ca2+ and organic cations are known to compete (65, 66). It is notable that the free Mg2+ concentrations used by our group and Blostein's group (as well as Ref. 45) were different by severalfold, as calculated from association constants with ATP and EDTA, pH, and ionic strength (Table III). In preliminary experiments with 7 mM free Mg2+, we observed a much lower overall Na+ affinity and a smaller effect of expression of gamma  in Na,K-ATPase from NRK-52E transfectants (data not shown). This is consistent with the concept that either Mg2+ or K+ can compete for Na+ binding. Measurements of free Mg2+ in cultured renal cells are in the range we used (67, 68), but free Mg2+ in skeletal, cardiac, and smooth muscle cells is as high as 1 mM (69).

Finally, the concentration of ATP may be a factor in determining K+/Na+ apparent antagonism through its effect on conformation, and this could introduce complexity either through the experimental use of different ATP concentrations, or through effects of gamma  on ATP affinity. However, if gamma  increases ATP affinity, it would be expected to reduce K+ affinity as a competitor and thus enhance Na+ apparent affinity, but this is the opposite of what is observed in gamma  transfectants. Conceptually, this is consistent with other evidence that effects of gamma  on Na+ affinity and on ATP affinity are distinct (21, 51).

Although prior papers have attempted to analyze gamma 's function effects in terms of a shift in Na,K-ATPase E1-E2 equilibrium, we think that this theoretical framework is not helpful. The data suggesting that gamma  favors E1 (or that anti-gamma antibody favors E2) are mostly based on observations in nonphysiological concentrations of ligands (29, 30), and seem to contradict the evidence that gamma  enhances K+ competition at intracellular Na+ sites (21). K+/Na+ competition should be inseparable from the loading of E2(K), E1(K), and E1(Na) intermediates and therefore inseparable from a tendency to remain in E2 (46, 53). gamma  has been proposed to increase K+ affinity as a competitor without affecting intrinsic Na+ affinity (51), but the very concept of an intrinsic Na+ affinity is complicated because, by the nature of vectorial transport, Na+ is always drained away. Although Na+ binding affinities for the three cytoplasmic sites can be estimated in the absence of ATP, a physically meaningful binding affinity cannot be obtained in its presence (at temperatures permissive for enzyme turnover) because of the failure to obtain equilibrium as a result of transport (53). Consequently, all reported Na+ affinities derived from enzyme during turnover are "apparent" affinities, regardless of how terms may be defined. These arguments, combined with the current concept that the pump cycle does not have any single "power stroke" that can be uniquely targeted to regulate activity (53), suggest that gamma , as an extra subunit, may impact multiple steps of the Post-Albers scheme. The ability of different forms of gamma  to affect Na+, K+, and ATP affinities separately argues that a reductionist attempt to understand mechanism as an effect on any one step may be difficult to accomplish.

A final physiological variable that we have not addressed is membrane potential (70). In proteoliposomes containing renal Na,K-ATPase, a potential positive on the cytoplasmic side (equivalent to cell depolarization) increased Na+ affinity without altering the affinity for competing K+ or organic cations (71). Membrane potential has been shown to affect the magnitude of the effects of both gamma  (28) and CHIF (32) to external Na+ and K+ measured in Xenopus oocytes. In short, the functional consequences of gamma  expression for Na,K-ATPase properties is potentially complex, and merits further investigation in intact cells.

In conclusion, apparent Na+ affinity can be affected by multiple factors: voltage; K+, Mg2+, and ATP concentrations for any given preparation; and expression of gamma  and CHIF for any given set of conditions. The data suggest that the effect gamma  has on the affinity of K+ as a competitor of Na+ binding is not quantitatively explained by a simple competition model.

Physiological Relevance of gamma  Expression-- It is notable that the level of gamma  expression in stably transfected clones is lower than that found in the renal medulla (21, 31). This may be because of the fact that gamma  expression can slow growth rates. We routinely observed that empty vector clones appeared several days before gamma -expressing clones, suggesting that there may be selective pressure against clones with even higher levels of expression.

This laboratory has recently shown that gamma  expression can be induced in NRK-52E cells by exposure to hypertonic media for six or more h (72). Others have reported a similar finding in inner medullary collecting duct cells (73). How this relates to conditions in the kidney is a matter of some importance, particularly because the expression of gamma  and each splice variant varies markedly in different nephron segments (22, 23), and the hypertonicity of the nephron varies with depth and physiological status.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant HL27653 (to K. J. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: 149-6118, Massachusetts General Hospital, 149 13th St., Charlestown, MA 02129. Tel.: 617-726-8579; Fax: 617-726-7526; E-mail: sweadner@helix.mgh.harvard.edu.

Published, JBC Papers in Press, December 27, 2001, DOI 10.1074/jbc.M111552200

2 A third, larger splice variant, gamma c, has been reported for mouse (36), but if it was present in adult mouse kidney, it was at levels that were not detected here.

3 D. H. Jones, Y. Li, K. J. Barr, E. Arystarkhova, R. K. Wetzel, K. J. Sweadner, G.-H. Fong, and G. M. Kidder, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: Na, K-ATPase, sodium and potassium-exchanging adenosine triphosphatase; HEK, human embryonic kidney; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; FXYD, gene nomenclature based on a conserved motif, Phe-X-Tyr-Asp, pronounced like "fix-it.".

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lingrel, J. B., Orlowski, J., Shull, M. M., and Price, E. M. (1990) Prog. Nucleic Acid Res. Mol. Biol. 38, 37-89[Medline] [Order article via Infotrieve]
2. Sweadner, K. J. (1989) Biochim. Biophys. Acta 988, 185-220[Medline] [Order article via Infotrieve]
3. Blanco, G., and Mercer, R. W. (1998) Am. J. Physiol. 275, F633-F650[Medline] [Order article via Infotrieve]
4. Feraille, E., Carranza, M. L., Rousselot, M., and Favre, H. (1994) Am. J. Physiol. 267, F55-F62[Medline] [Order article via Infotrieve]
5. Feraille, E., Carranza, M. L., Buffin-Meyer, B., Rousselot, M., Doucet, A., and Favre, H. (1995) Am. J. Physiol. 268, C1277-C1283[Medline] [Order article via Infotrieve]
6. Buffin-Meyer, B., Marsy, S., Barlet-Bas, C., Cheval, L., Younes-Ibrahim, M., Rajerison, R., and Doucet, A. (1996) J. Physiol. 490, 623-632[Abstract/Free Full Text]
7. Barlet Bas, C., Cheval, L., Khadouri, C., Marsy, S., and Doucet, A. (1990) Am. J. Physiol. 259, F246-F250[Medline] [Order article via Infotrieve]
8. Farman, N., Corthesy-Theulaz, I., Bonvalet, J. P., and Rossier, B. C. (1991) Am. J. Physiol. C468-C474
9. Welling, P. A., Caplan, M., Sutters, M., and Giebisch, G. (1993) J. Biol. Chem. 268, 23469-23476[Abstract/Free Full Text]
10. Tumlin, J. A., Hoban, C. A., Medford, R. M., and Sands, J. M. (1994) Am. J. Physiol. 266, F240-F245[Medline] [Order article via Infotrieve]
11. Lucking, K., Nielsen, J. M., Pedersen, P. A., and Jorgensen, P. L. (1996) Am. J. Physiol. 271, F253-F260[Medline] [Order article via Infotrieve]
12. Hayward, A. L., Hinojos, C. A., Nurowska, B., Hewetson, A., Sabatini, S., Oefner, P. J., and Doris, P. A. (1999) J. Hypertens. 17, 1081-1087[CrossRef][Medline] [Order article via Infotrieve]
13. Forbush, B., III, Kaplan, J. H., and Hoffman, J. F. (1978) Biochemistry 17, 3667-3676[CrossRef][Medline] [Order article via Infotrieve]
14. Mercer, R. W., Biemesderfer, D., Bliss, D. P., Jr., Collins, J. H., and Forbush, B., III. (1993) J. Cell Biol. 121, 579-586[Abstract/Free Full Text]
15. Attali, B., Latter, H., Rachamim, N., and Garty, H. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6092-6096[Abstract/Free Full Text]
16. Shi, H., Levy-Holzman, R., Cluzeaud, F., Farman, N., and Garty, H. (2001) Am. J. Physiol. 280, F505-F512
17. Palmer, C. J., Scott, D., and Jones, L. R. (1991) J. Biol. Chem. 266, 11126-11130[Abstract/Free Full Text]
18. Morrison, B. W., Moorman, J. R., Kowdley, G. C., Kobayashi, Y. M., Jones, L. R., and Leder, P. (1995) J. Biol. Chem. 270, 2176-2182[Abstract/Free Full Text]
19. Fu, X., and Kamps, M. P. (1997) Mol. Cell. Biol. 17, 1503-1512[Abstract]
20. Sweadner, K. J., and Rael, E. (2000) Genomics 68, 41-56[CrossRef][Medline] [Order article via Infotrieve]
21. Pu, H. X., Cluzeaud, F., Goldshleger, R., Karlish, S. J. D., Farman, N., and Blostein, R. (2001) J. Biol. Chem. 276, 20370-20378[Abstract/Free Full Text]
22. Wetzel, R. K., and Sweadner, K. J. (2001) Am. J. Physiol. 281, F531-F545
23. Arystarkhova, E., Wetzel, R. K., and Sweadner, K. J. (2002) Am. J. Physiol. 282, F393-F407
24. Freytag, J. W. (1983) FEBS Lett. 159, 280-284[CrossRef][Medline] [Order article via Infotrieve]
25. DeTomaso, A. W., Xie, Z. J., Liu, G., and Mercer, R. W. (1993) J. Biol. Chem. 268, 1470-1478[Abstract/Free Full Text]
26. Scheiner-Bobis, G., and Farley, R. A. (1994) Biochim. Biophys. Acta 1193, 226-234[Medline] [Order article via Infotrieve]
27. Geering, K., Beggah, A., Good, P., Girardet, S., Roy, S., Schaer, D., and Jaunin, P. (1996) J. Cell Biol. 133, 1193-1204[Abstract/Free Full Text]
28. Beguin, P., Wang, X., Firsov, D., Puoti, A., Claeys, D., Horisberger, J. D., and Geering, K. (1997) EMBO J. 16, 4250-4260[CrossRef][Medline] [Order article via Infotrieve]
29. Therien, A. G., Goldshleger, R., Karlish, S. J. D., and Blostein, R. (1997) J. Biol. Chem. 272, 32628-32634[Abstract/Free Full Text]
30. Therien, A. G., Karlish, S. J. D., and Blostein, R. (1999) J. Biol. Chem. 274, 12252-12256[Abstract/Free Full Text]
31. Arystarkhova, E., Wetzel, R. K., Asinovski, N. K., and Sweadner, K. J. (1999) J. Biol. Chem. 274, 33183-33185[Abstract/Free Full Text]
32. Beguin, P., Crambert, G., Guennoun, S., Garty, H., Horisberger, J.-D., and Geering, K. (2001) EMBO J. 20, 3993-4002[CrossRef][Medline] [Order article via Infotrieve]
33. Feraille, E., Rousselot, M., Rajerison, R., and Favre, H. (1995) J. Physiol. 488, 171-180[Abstract/Free Full Text]
34. Sweadner, K. J., Rael, E., Wetzel, R. K., and Arystarkhova, E. (2000) in Na/K-ATPase and Related ATPases (Taniguchi, K. , and Kaya, S., eds) , pp. 543-546, Elsevier, Amsterdam
35. Küster, B., Shainskaya, A., Pu, H. X., Goldshleger, R., Blostein, R., and Karlish, S. J. D. (2000) J. Biol. Chem. 275, 18441-18446[Abstract/Free Full Text]
36. Jones, D. H., Golding, M. C., Barr, K. J., Fong, G.-H., and Kidder, G. M. (2001) Physiol. Genom. 6, 129-135[Abstract/Free Full Text]
37. Sweadner, K. J., Wetzel, R. K., and Arystarkhova, E. (2000) Biochem. Biophys. Res. Commun. 279, 196-201[CrossRef][Medline] [Order article via Infotrieve]
38. Arystarkhova, E., Wetzel, R. K., Rael, E., Asinovski, N. K., and Sweadner, K. (2000) Biophys. J. 78, 279A
39. Arystarkhova, E., Asinovski, N. K., and Sweadner, K. J. (2000) J. Am. Soc. Nephrol. 11, 24A
40. Jorgensen, P. L. (1974) Methods Enzymol. 32, 277-290[Medline] [Order article via Infotrieve]
41. Schagger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379[CrossRef][Medline] [Order article via Infotrieve]
42. Arystarkhova, E., and Sweadner, K. J. (1996) J. Biol. Chem. 271, 23407-23417[Abstract/Free Full Text]
43. Sweadner, K. J. (1985) J. Biol. Chem. 260, 11508-11513[Abstract/Free Full Text]
44. Garay, R., and Garrahan, P. J. (1973) J. Physiol. 231, 297-325[Abstract/Free Full Text]
45. Sachs, J. R. (1986) J. Physiol. 374, 221-244[Abstract/Free Full Text]
46. Therien, A. G., Nestor, N. B., Ball, W. J., and Blostein, R. (1996) J. Biol. Chem. 271, 7104-7112[Abstract/Free Full Text]
47. Arystarkhova, E., Wetzel, R. K., Asinovski, N. K., and Sweadner, K. J. (2000) in Na/K-ATPase and Related ATPases (Taniguchi, K. , and Kaya, S., eds) , pp. 489-496, Elsevier, Amsterdam
48. Feraille, E., and Doucet, A. (2001) Physiol. Rev. 81, 345-418[Abstract/Free Full Text]
49. Starling, A. P., Sharma, R. P., East, J. M., and Lee, A. G. (1996) Biochem. Biophys. Res. Commun. 226, 352-355[CrossRef][Medline] [Order article via Infotrieve]
50. Aperia, A. (2001) Curr. Hypertens. Rep. 3, 165-171[Medline] [Order article via Infotrieve]
51. Therien, A. G., Pu, H. X., Karlish, S. J. D., and Blostein, R. (2001) J. Bioenerg. Biomembr. 33, 407-414[CrossRef][Medline] [Order article via Infotrieve]
52. Burrow, C. R., Devuyst, O., Li, X., Gatti, L., and Wilson, P. D. (1999) Am. J. Physiol. 277, F391-F403[Medline] [Order article via Infotrieve]
53. Apell, H.-J., and Karlish, S. J. (2001) J. Membr. Biol. 180, 1-9[CrossRef][Medline] [Order article via Infotrieve]
54. Therien, A. G., and Blostein, R. (1999) Am. J. Physiol. 277, C891-C898[Medline] [Order article via Infotrieve]
55. Domaszewicz, W., and Apell, H.-J. (1999) FEBS Lett. 458, 241-246[CrossRef][Medline] [Order article via Infotrieve]
56. Holmgren, M., Wagg, J., Benzanilla, F., Rakowski, R. F., De, Weer, P., and Gadsby, D. C. (2000) Nature 403, 898-901[CrossRef][Medline] [Order article via Infotrieve]
57. Rossi, R. C., and Garrahan, P. J. (1989) Biochim. Biophys. Acta 981, 105-114
58. Nakao, M., and Gadsby, D. C. (1989) J. Gen. Physiol. 94, 539-565[Abstract/Free Full Text]
59. Barmashenko, G., Kockskamper, G., and Glitsch, H. G. (1999) J. Physiol. 517, 691-698[CrossRef][Medline] [Order article via Infotrieve]
60. Robinson, J. D., and Davis, R. L. (1987) Biochim. Biophys. Acta 912, 343-347[CrossRef][Medline] [Order article via Infotrieve]
61. Robinson, J. D., and Pratap, P. R. (1991) Biochim. Biophys. Acta 1069, 281-287[Medline] [Order article via Infotrieve]
62. Sachs, J. R. (1988) J. Physiol. 400, 575-591[Abstract/Free Full Text]
63. Robinson, J. D., and Pratap, P. R. (1991) Biochim. Biophys. Acta 1061, 267-278[Medline] [Order article via Infotrieve]
64. Schneeberger, A., and Apell, H.-J. (1999) J. Membr. Biol. 168, 221-228[CrossRef][Medline] [Order article via Infotrieve]
65. Schneeberger, A., and Apell, H.-J. (2001) J. Membr. Biol. 179, 263-273[CrossRef][Medline] [Order article via Infotrieve]
66. Hoving, S., Bar-Shimon, M., Tijmes, J. J., Goldshleger, R., Tal, D. M., and Karlish, S. J. D. (1995) J. Biol. Chem. 270, 29788-29793[Abstract/Free Full Text]
67. Dai, L.-J., Ritchie, G., Kerstan, D., Kang, H. S., Cole, D. E. C., and Quamme, G. A. (2001) Physiol. Rev. 81, 51-84[Abstract/Free Full Text]
68. Touyz, R. M., Mercure, C., and Reudelhuber, T. L. (2001) J. Biol. Chem. 276, 13657-13663[Abstract/Free Full Text]
69. Tashiro, M., and Konishi, M. (1997) Biophys. J. 73, 3358-3370[Medline] [Order article via Infotrieve]
70. Gadsby, D. C., Kimura, J., and Noma, A. (1985) Nature 315, 63-65[CrossRef][Medline] [Order article via Infotrieve]
71. Or, E., Goldshleger, R., and Karlish, S. J. D. (1996) J. Biol. Chem. 271, 2470-2477[Abstract/Free Full Text]
72. Wetzel, R. K., Asinovski, N. K., Arystarkhova, E., and Sweadner, K. J. (2001) J. Am. Soc. Nephrol. 12, 43A
73. Capasso, J. M., Rivard, C., and Berl, T. (2001) Proc. Natl. Acad. Sci. U. S. A. 23, 3414-3419


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Lubarski, S. J. D. Karlish, and H. Garty
Structural and functional interactions between FXYD5 and the Na+-K+-ATPase
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1818 - F1826.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Kobayashi, Y. Tahara, H. Takenaka, K. Mimura, and Y. Hayashi
Na+- and K+-Dependent Oligomeric Interconversion among {alpha}{beta}-Protomers, Diprotomers and Higher Oligomers in Solubilized Na+/K+-ATPase
J. Biochem., August 1, 2007; 142(2): 157 - 173.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Arystarkhova, C. Donnet, A. Munoz-Matta, S. C. Specht, and K. J. Sweadner
Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and {gamma}-subunit in response to stress
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1179 - C1191.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A.-N. T. Nguyen, D. P. Wallace, and G. Blanco
Ouabain Binds with High Affinity to the Na,K-ATPase in Human Polycystic Kidney Cells and Induces Extracellular Signal-Regulated Kinase Activation and Cell Proliferation
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Han, J. Bossuyt, S. Despa, A. L. Tucker, and D. M. Bers
Phospholemman Phosphorylation Mediates the Protein Kinase C-Dependent Effects on Na+/K+ Pump Function in Cardiac Myocytes
Circ. Res., December 8, 2006; 99(12): 1376 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Pihakaski-Maunsbach, H. Vorum, B. Honore, S. Tokonabe, J. Frokiaer, H. Garty, S. J. D. Karlish, and A. B. Maunsbach
Locations, abundances, and possible functions of FXYD ion transport regulators in rat renal medulla
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1033 - F1044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bossuyt, S. Despa, J. L. Martin, and D. M. Bers
Phospholemman Phosphorylation Alters Its Fluorescence Resonance Energy Transfer with the Na/K-ATPase Pump
J. Biol. Chem., October 27, 2006; 281(43): 32765 - 32773.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Geering
FXYD proteins: new regulators of Na-K-ATPase
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F241 - F250.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Bossuyt, X. Ai, J. R. Moorman, S. M. Pogwizd, and D. M. Bers
Expression and Phosphorylation of the Na-Pump Regulatory Subunit Phospholemman in Heart Failure
Circ. Res., September 16, 2005; 97(6): 558 - 565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Mahmmoud, H. Vorum, and F. Cornelius
Interaction of FXYD10 (PLMS) with Na,K-ATPase from Shark Rectal Glands: CLOSE PROXIMITY OF Cys74 OF FXYD10 TO Cys254 IN THE A DOMAIN OF THE {alpha}-SUBUNIT REVEALED BY INTERMOLECULAR THIOL CROSS-LINKING
J. Biol. Chem., July 29, 2005; 280(30): 27776 - 27782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. H. Jones, T. Y. Li, E. Arystarkhova, K. J. Barr, R. K. Wetzel, J. Peng, K. Markham, K. J. Sweadner, G.-H. Fong, and G. M. Kidder
Na,K-ATPase from Mice Lacking the {gamma} Subunit (FXYD2) Exhibits Altered Na+ Affinity and Decreased Thermal Stability
J. Biol. Chem., May 13, 2005; 280(19): 19003 - 19011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fuzesi, K.-E. Gottschalk, M. Lindzen, A. Shainskaya, B. Kuster, H. Garty, and S. J. D. Karlish
Covalent Cross-links between the {gamma} Subunit (FXYD2) and {alpha} and {beta} Subunits of Na,K-ATPase: MODELING THE {alpha}-{gamma} INTERACTION
J. Biol. Chem., May 6, 2005; 280(18): 18291 - 18301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L.-G. Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H. Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, et al.
Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1982 - H1988.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Wetzel, J. L. Pascoa, and E. Arystarkhova
Stress-induced Expression of the {gamma} Subunit (FXYD2) Modulates Na,K-ATPase Activity and Cell Growth
J. Biol. Chem., October 1, 2004; 279(40): 41750 - 41757.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. S. Lee, K. Hanspers, C. S. Barker, A. P. Korn, and J. M. McCune
Gene expression profiles during human CD4+ T cell differentiation
Int. Immunol., August 1, 2004; 16(8): 1109 - 1124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Mahmmoud, G. Cramb, A. B Maunsbach, C. P. Cutler, L. Meischke, and F. Cornelius
Regulation of Na,K-ATPase by PLMS, the Phospholemman-like Protein from Shark: MOLECULAR CLONING, SEQUENCE, EXPRESSION, CELLULAR DISTRIBUTION, AND FUNCTIONAL EFFECTS OF PLMS
J. Biol. Chem., September 26, 2003; 278(39): 37427 - 37438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. K. Wetzel and K. J. Sweadner
Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F121 - F129.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
F. Cornelius and Y. A. Mahmmoud
Functional Modulation of the Sodium Pump: The Regulatory Proteins "Fixit"
Physiology, June 1, 2003; 18(3): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. S. Feschenko, C. Donnet, R. K. Wetzel, N. K. Asinovski, L. R. Jones, and K. J. Sweadner
Phospholemman, a Single-Span Membrane Protein, Is an Accessory Protein of Na,K-ATPase in Cerebellum and Choroid Plexus
J. Neurosci., March 15, 2003; 23(6): 2161 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
G. Crambert and K. Geering
FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase
Sci. Signal., January 21, 2003; 2003(166): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Crambert, M. Fuzesi, H. Garty, S. Karlish, and K. Geering
Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties
PNAS, August 20, 2002; 99(17): 11476 - 11481.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/12/10162    most recent
M111552200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arystarkhova, E.
Right arrow Articles by Sweadner, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arystarkhova, E.
Right arrow Articles by Sweadner, K. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement